W9Q-38216-00677
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 471 / IN
- Registered
- 2021-08-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-09
Registered in v-safe
-
2021-08-09
Dose 1 — Pfizer-BioNTech
- 2021-08-09
- 2021-08-10
- 2021-08-11
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-23
-
2021-08-30
Dose 2 — Pfizer-BioNTech
- 2021-08-30
-
2021-08-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-13
-
2021-09-20
Survey response — day 21, dose 2MedDRA: Cough, Ear pain, Oropharyngeal pain, Paranasal sinus discomfort, Paranasal sinus hypersecretion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, sinus pressure, sinus drainage, sore throat, ear acheMedDRA releases: 2024-11 · check-in free text available
-
2021-09-20
Report sent to call center — day 21, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-23
- 2021-09-27
- 2021-10-06
- 2021-10-11
- 2021-11-29
- 2022-02-28
-
2022-08-30
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Contracted covid in early JulyMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-31
Call successfulDoes not wish to fill out VAERS report
-
2022-08-31
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-09 | Pfizer-BioNTech | No |
| 2 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-20 | Successful 2022-08-31 |
Does not wish to fill out VAERS report |
| 2022-08-30 | Successful 2022-08-31 |
Does not wish to fill out VAERS report |
Free text
Release 9 — day 21, dose 2
Symptoms: Cough, sinus pressure, sinus drainage, sore throat, ear ache
Release 12 — 12 months, dose 2
Symptoms: Contracted covid in early July
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release